U.S. FDA approves updated COVID-19 vaccines against currently circulating variants
The FDA said the updated vaccines will target the Omicron variant KP.2 strain.
PREMIUM Health
A medical staff member prepares a dose of COVID-19 vaccine at a vaccine clinic in San Antonio, Texas, the United States, Jan. 9, 2022. (Photo by Xinhua)
NewVision Reporter
@NewVision
The U.S. Food and Drug Administration (FDA) on Thursday approved and granted emergency use authorization for updated mRNA COVID-19 vaccines to better protect against currently circulating variants.
The FDA